{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:44:10Z","timestamp":1791845050347,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.soncn.2021.151136","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T08:08:41Z","timestamp":1616054921000},"page":"151136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Tumor Lysis Syndrome: Implications for Oncology Nursing Practice"],"prefix":"10.1016","volume":"37","author":[{"given":"Jennifer S.","family":"Webster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Kaplow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.soncn.2021.151136_bib0001","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.NURSE.0000502751.87828.2d","article-title":"Recognizing and preventing tumor lysis syndrome","volume":"46","author":"Kaplow","year":"2016","journal-title":"Nursing"},{"issue":"6","key":"10.1016\/j.soncn.2021.151136_bib0002","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jamaoncol.2018.0613","article-title":"Tumor lysis syndrome","volume":"4","author":"Gupta","year":"2018","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.soncn.2021.151136_bib0003","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5858\/arpa.2017-0278-RS","article-title":"Tumor lysis syndrome","volume":"143","author":"Williams","year":"2019","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.soncn.2021.151136_bib0004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/2399369319837212","article-title":"Update on the prevention and treatment of tumor lysis syndrome","volume":"3","author":"Sury","year":"2019","journal-title":"J Onco-Nephrol"},{"issue":"3","key":"10.1016\/j.soncn.2021.151136_bib0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.emc.2018.04.007","article-title":"Pediatric oncologic emergencies","volume":"36","author":"Stephanos","year":"2018","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.soncn.2021.151136_bib0006","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9684909","article-title":"Tumor lysis syndrome in patients with hematological malignancies","volume":"2017","author":"Belay","year":"2017","journal-title":"J Oncol"},{"key":"10.1016\/j.soncn.2021.151136_bib0007","unstructured":"Ikeda AK. What is the global incidence of tumor lysis syndrome (TLS)? Available at: https:\/\/www.medscape.com\/answers\/282171-55953\/what-is-the-global-incidence-of-tumor-lysis-syndrome-tls. Accessed December 14, 2020."},{"issue":"4","key":"10.1016\/j.soncn.2021.151136_bib0008","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00277-015-2585-7","article-title":"Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review","volume":"95","author":"Howard","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.soncn.2021.151136_bib0009","unstructured":"Ikeda AK. What iatrogenic complications may occur with tumor lysis syndrome? Available at: https:\/\/www.medscape.com\/answers\/282171-55958\/what-iatrogenic-complications-may-occur-with-tumor-lysis-syndrome-tls. Accessed December 17, 2020."},{"key":"10.1016\/j.soncn.2021.151136_bib0010","series-title":"StatPearls","article-title":"Hyperphosphatemia","author":"Goyal","year":"2021"},{"key":"10.1016\/j.soncn.2021.151136_bib0011","series-title":"StatPearls","article-title":"Hyperkalemia","author":"Simon","year":"2021"},{"key":"10.1016\/j.soncn.2021.151136_bib0012","unstructured":"Suneja M. Hypocalcemia clinical presentation. Available at: https:\/\/emedicine.medscape.com\/article\/241893-clinical. Accessed December 16, 2020."},{"issue":"1","key":"10.1016\/j.soncn.2021.151136_bib0013","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo","year":"2004","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.soncn.2021.151136_bib0014","first-page":"705","article-title":"Managing tumor lysis syndrome in the era of novel cancer therapies","volume":"8","author":"McBride","year":"2017","journal-title":"J Adv Pract Oncol"},{"key":"10.1016\/j.soncn.2021.151136_bib0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1159\/000509934","article-title":"Prevention and treatment of tumor lysis syndrome in the era of onco-nephrology progress","volume":"45","author":"Matuszkiewicz-Rowinska","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.soncn.2021.151136_bib0016","unstructured":"Horwitz SM, Ansell S, Ai WZ, et al. T-cell lymphomas. NCCN Guidelines Version 1.2021. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/t-cell.pdf. Accessed January, 2, 2021."},{"issue":"2","key":"10.1016\/j.soncn.2021.151136_bib0017","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1188\/16.CJON.195-200","article-title":"Preventing tumor lysis syndrome: Two case studies of unexpected outcomes","volume":"20","author":"Sleutel","year":"2016","journal-title":"Clin J Oncol Nurs"},{"issue":"11","key":"10.1016\/j.soncn.2021.151136_bib0018","first-page":"21","article-title":"G6PD deficiency: an update","volume":"32","author":"Harcke","year":"2019","journal-title":"J Am Acad Phys Assist"},{"issue":"4","key":"10.1016\/j.soncn.2021.151136_bib0019","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.2010.08143.x","article-title":"TLS expert panel. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus","volume":"149","author":"Cairo","year":"2010","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.soncn.2021.151136_bib0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1188\/17.CJON.604-610","article-title":"Venetoclax: management and care for patients with relapsed or refractory chronic lymphocytic leukemia","volume":"21","author":"Paradis","year":"2017","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.soncn.2021.151136_bib0021","series-title":"Tumor lysis syndrome","author":"Farkas","year":"2020"},{"issue":"4","key":"10.1016\/j.soncn.2021.151136_bib0022","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.amjms.2018.11.018","article-title":"Allopurinol-induced Stevens-Johnson syndrome","volume":"357","author":"Gupta","year":"2019","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.soncn.2021.151136_bib0023","unstructured":"Ikeda AK. How is hyperkalemia managed in tumor lysis syndrome (TLS)? Available at: https:\/\/www.medscape.com\/answers\/282171-55988\/how-is-hyperkalemia-managed-in-tumor-lysis-syndrome-tls. Accessed December 16, 2020."},{"key":"10.1016\/j.soncn.2021.151136_bib0024","unstructured":"Ikeda AK. Tumor lysis syndrome treatment and management. Available at: https:\/\/emedicine.medscape.com\/article\/282171-treatment#d15. Accessed January 7, 2021."},{"issue":"3","key":"10.1016\/j.soncn.2021.151136_bib0025","article-title":"Management of rasburicase-induced hemolytic anemia","volume":"8","author":"Kaland","year":"2018","journal-title":"J Hematol Oncol Pharm"},{"issue":"2","key":"10.1016\/j.soncn.2021.151136_bib0026","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40264-014-0255-7","article-title":"Risk of anaphylaxis with repeated courses of rasburicase: a Research on Adverse Drug Events and Reports (RADAR) project","volume":"38","author":"Allen","year":"2015","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.soncn.2021.151136_bib0027","first-page":"30","article-title":"Effectiveness of a single 6-mg fixed dose of rasburicase for prevention or management of hyperuricemia associated with tumor lysis syndrome in adults with cancer","volume":"9","author":"Khan","year":"2019","journal-title":"J Hepato Oncol Pharm"},{"issue":"3","key":"10.1016\/j.soncn.2021.151136_bib0028","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.clml.2016.11.003","article-title":"A clinical and economic comparison of rasburicase and allopurinol in the treatment of patients with clinical or laboratory tumor lysis syndrome","volume":"17","author":"Cairo","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.soncn.2021.151136_bib0029","unstructured":"Ikeda AK. What is the role of dietary restrictions in the management of tumor lysis syndrome. Available at: https:\/\/www.medscape.com\/answers\/282171-55978\/what-is-the-role-of-dietary-restrictions-in-the-management-of-tumor-lysis-syndrome. Accessed December 17, 2020."},{"issue":"11","key":"10.1016\/j.soncn.2021.151136_bib0030","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.autrev.2018.05.008","article-title":"Nutritional recommendations for gout: an update from clinical epidemiology","volume":"17","author":"Nielsen","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.soncn.2021.151136_bib0031","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.amjmed.2016.06.040","article-title":"Update on importance of diet in gout","volume":"129","author":"Beyl","year":"2016","journal-title":"Am J Med"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074920812100019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074920812100019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:35:46Z","timestamp":1760081746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074920812100019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S074920812100019X"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2021.151136","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor Lysis Syndrome: Implications for Oncology Nursing Practice","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2021.151136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151136"}}